Form 4: J&J Director Acquires Deferred Share Units

Johnson & Johnson Director Daniel E. Pinto acquired 175.493 Deferred Share Units as part of a compensation plan.

Summary

• Daniel E. Pinto, a Director of Johnson & Johnson (JNJ), acquired 175.493 Deferred Share Units (DSUs) on September 9, 2025.
• The acquisition was made under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• DSUs represent the deferral of a cash retainer and are to be settled in cash upon the termination of Mr. Pinto's directorship.
• Each DSU represents the fair market value of one share of Common Stock on the business day prior to the settlement date.
• The reported price of the derivative security (DSU) was $178.07.

Sentiment

Score: 7

Explanation: The filing details a routine insider transaction related to director compensation, which is generally viewed as a neutral to slightly positive event as it aligns director interests with shareholders without indicating any new operational or financial developments.

Positives

• The acquisition of Deferred Share Units by a director aligns their long-term financial interests with the company's performance, fostering a commitment to shareholder value.
• This transaction is part of a structured compensation plan, indicating a routine and expected component of director remuneration.

Future Outlook

The Deferred Share Units acquired by Daniel E. Pinto are scheduled to be settled in cash upon the termination of his directorship with Johnson & Johnson.

Industry Context

The acquisition of Deferred Share Units as part of director compensation is a common practice among large publicly traded companies. This mechanism is widely used to align the interests of board members with the long-term performance and shareholder value of the company, reflecting standard corporate governance practices.

Comparison to Industry Standards

• Deferred compensation plans for directors, such as the one utilized by Johnson & Johnson, are standard practice across major corporations like Pfizer, Merck, and Abbott Laboratories. These plans typically involve granting equity-linked units that vest or settle upon departure, ensuring long-term commitment.
• The structure of DSUs, where each unit represents the fair market value of one share of common stock, is a prevalent method to tie director compensation directly to stock performance, similar to practices at companies like Procter & Gamble or Coca-Cola.

Related Party Transactions

• Acquisition of 175.493 Deferred Share Units by Director Daniel E. Pinto as part of the company's Amended and Restated Deferred Fee Plan for Directors.

Stakeholder Impact

• Shareholders: The acquisition of Deferred Share Units by a director aligns their long-term financial interests with the company's performance, potentially fostering more shareholder-centric decision-making.

Next Steps

• Settlement of the Deferred Share Units in cash upon the termination of Daniel E. Pinto's directorship.

Key Dates

Recommendation

This Form 4 filing details a routine acquisition of Deferred Share Units by a director as part of their compensation plan. It does not present new information that would significantly alter the investment thesis for Johnson & Johnson, thus a 'hold' recommendation is maintained. The transaction is an expected part of director remuneration and does not signal any material operational or strategic changes.

Keywords

Johnson & Johnson, JNJ, Daniel E. Pinto, Form 4, SEC filing, Deferred Share Units, DSU, Director compensation, Insider transaction